Estrogen deficiency-induced alterations of vascular MMP-2, MT1-MMP, and TIMP-2 in ovariectomized rats

American Journal of Hypertension

Volumn 22, Issue 1, 2009, Pages 27-34

  Lam, Kwok Keung ^a,b   Cheng, Pao Yun ^c   Hsiao, George ^a   Chen, Shu Ying ^d   Shen, Hsin Hsueh ^e   Yen, Mao Hsiung ^f   Lee, Yen Mei ^f  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b Catholic Mercy Hospital Hsinchu   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d HUNGKUANG UNIVERSITY   (Taiwan)

^e KAOHSIUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^f NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; COLLAGEN; ESTRADIOL; GELATINASE A; MATRIX METALLOPROTEINASE 14; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TEMPOL; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE FLUCTUATION; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; ESTROGEN DEFICIENCY; FEMALE; HYPERTENSION; IN VIVO STUDY; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; POSTMENOPAUSE HYPERTENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; AORTA, THORACIC; BLOOD PRESSURE; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ESTROGENS; FEMALE; FOLLOW-UP STUDIES; HYPERTENSION; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; OVARIECTOMY; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE INHIBITOR OF METALLOPROTEINASE-2; VASCULAR RESISTANCE;

EID: 57749208369     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2008.306     Document Type: Article

References (36)

1. Tayebjee MH, MacFadyen RJ, Lip GYH. Extracellular matrix biology: a new frontier in linking the pathology and therapy of hypertension. J Hypertens 2003; 21:2211-2218.
2. Jacob MP. Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. Biomed Pharmacother 2003; 57:195-202.
3. Murphy G, Docherty AJP. The matrix metalloproteinases and their inhibitors in connective tissue remodeling. Am J Respir Cell Mol Biol 1992; 7:120-125.
4. Woessner JF Jr. The family of matrix metalloproteinases. Ann NY Acad Sci 1994; 732:11-21.
5. Donnelly R, Collinson DJ, Manning G. Hypertension, matrix metalloproteinases and target organ damage. J Hypertens 2003; 21:1627-1630.
6. Ward RV, Hembry RM, Reynolds JJ, Murphy G. The purification of TIMP2 from its 72 kDa pro-gelatinase complex. Biochem J 1991; 278:179-187.
7. Ellerbroek SM, Wu YI, Overall CM, Stack MS. Functional interplay between type 1 collagen and cell surface matrix metalloproteinase activity. J Biol Chem 2001; 276:24833-24842.
8. 2+ channel antagonists on plasma concentrations of matrix metalloproteinase-2 and -9 in essential hypertension. Am J Hypertens 2004; 17:273-276.
9. Spiers JP, Kelso EJ, Siah WF, Edge G, Song G, McDermott BJ, Hennessy M. Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension: effects of endothelin receptor blockade. J Hypertens 2005; 23:1717-1724.
10. Chesler N, Ku D, Galis ZS. Transmural pressure induces matrix degrading activity in porcine arteries ex vivo. Am J Physiol 1999; 277:H2002-H2009.
11. Zhang Y, Stewart KG, Davidge ST. Estrogen replacement reduces age-associated remodeling in rat mesenteric arteries. Hypertension 2000; 36: 970-974.
12. Nelson K, Melendez JA. The powerhouse takes control of the cell: the role of mitochondria in signal transduction. Free Radic Biol Med 2004; 37:768-784.
13. Steudel W, Scherrer-Crosbie M, Bloch KD, Weimann J, Huang PL, Jones RC, Picard MH, Zapol WM. Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J Clin Invest 1998; 101:2468-2477.
14. Arribas SM, Gonzalez C, Graham D, Dominiczak AF, McGrath JC. Cellular changes induced by chronic nitric oxide inhibition in intact rat basilar arteries revealed by confocal microscopy. J Hypertens 1997; 15:1685-1693.
15. Mitchell JB, DeGraff W, Kaufman D, Krishna MC, Samuni A, Finkelstein E, Ahn MS, Hahn SM, Gamson J, Russo A. Inhibition of oxygen-dependent radiation-induced damage by nitroxide superoxide dismutase mimic, tempol. Arch Biochem Biophys 1991; 289:62-70.
16. Cuzzocrea S, McDonald MC, Mazzon E, Siriwardena D, Costantino G, Fulia F, Cucinotta G, Gitto E, Cordaro S, Barberi I, De Sarro A, Caputi AP, Thiemermann C. Effects of tempol, a membrane-permeable radical scavenger, in a gerbil model of brain injury. Brain Res 2000; 875:96-106.
17. Prockop DJ, Kivirikko KI. Collagens: molecular biology, diseases, and potentials for therapy. Annu Rev Biochem 1995; 64:403-434.
18. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17:463-516.
19. Lee YM, Cheng PY, Hong SF, Chen SY, Lam KK, Sheu JR, Yen MH. Oxidative stress induces vascular heme oxygenase-1 expression in ovariectomized rats. Free Radic Biol Med 2005; 39:108-117.
20. Itoh Y, Seiki M. MT1-MMP: a potent modifier of pericellular microenvironment. J Cell Physiol 2006; 206:1-8.
21. Garcia PM, Gimenez J, Bonacasa B, Carbonell LF, Miguel SG, Quesada T, Hernandez I. Estrogen exerts a beneficial effect on coronary vascular remodeling in the early stages of hypertension in spontaneously hypertensive rats. Menopause 2005; 12:453-459.
22. Wingrove CS, Garr E, Godsland IF, Stevenson JC. 17 beta-oestradil enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells. Biochim Biophys Acta 1998; 1406:169-174.
23. Guccione M, Silbiger S, Lei J, Neugarten J. Estradiol upregulates mesangial cell MMP-2 activity via the transcription factor AP-2. Am J Physiol-Renal Physiol 2002; 282:F164-F169.
24. Dubey RK, Jackson EK. Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. Am J Physiol-Renal Physiol 2001; 280:F365-F388.
25. Shwaery GT, Vita JA, Keaney FR Jr. Antioxidant protection of LDL by physiological concentratons of 17 beta-estradiol. Requirement for estradiol modification. Circulation 1997; 95:1378-1385.
26. Dubey RK, Tyurina YY, Tyurin VA, Gillespie DG, Branch RA, Jackson EK, Kagan VE. Estrogen and tamoxifen metabolites protect smooth muscle cell membrane phospholipids against peroxidation and inhibit cell growth. Circ Res 1999; 84:229-239.
27. Dantas AP, Tostes RC, Fortes ZB, Costa SG, Nigro D, Carvalho MH. In vivo evidence for antioxidant potential of estrogen in microvessels of female spontaneously hypertensive rats. Hypertension 2002; 39:405-411.
28. Wassmann S, Baumer AT, Strehlow K, van Eickels M, Grohe C, Ahlbory K, Rosen R, Bohm M, Nickenig G. Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats. Circulation 2001; 103:435-441.
29. Lacort M, Leal AM, Liza M, Martin C, Martinez R, Ruiz-Larrea MB. Protective effect of estrogens and catecholestrogens against peroxidative membrane damage in vitro. Lipids 1995; 30:141-146.
30. Ruiz-Larrea MB, Martin C, Martinez R, Navarro R, Lacort M, Miller NJ. Antioxidant activities of estrogens against aqueous and lipophilic radicals; differences between phenol and catechol estrogens. Chem Phys Lipids 2000; 105:179-188.
31. Signorelli SS, Neri S, Sciacchitano S, Pino LD, Costa MP, Pennisi G, Ierna D, Caschetto S. Duration of menopause and behavior of malondialdehyde, lipids, lipoproteins and carotid wall artery intima-media thickness. Maturitas 2001; 39:39-42.
32. Lam KK, Lee YM, Hsiao G, Chen SY, Yen MH. Estrogen therapy replenishes vascular tetrahydrobiopterin and reduces oxidative stress in ovariectomized rats. Menopause 2006; 13:294-302.
33. Matsunaga T, Weihrauch DW, Moniz MC, Tessmer J, Warltier DC, Chilian WM. Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide. Circulation 2002; 105:2185-2191.
34. Owens MW, Milligan SA, Jourd'heuil D, Grisham MB. Effects of reactive metabolites of oxygen and nitrogen on gelatinase A activity. Am J Physiol-Lung Cell Mol Physiol 1997; 273:L445-L450.
35. Thornalley PJ. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch Biochem Biophys 2003; 419:31-40.
36. Safar ME, Smulyan H. Hypertension in women. Am J Hypertens 2004; 17:82-87.